The aim of this study was to investigate the effect of interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α) on NADPH oxidase activity and gp91-phox gene expression in HL-60 clone 15 cells as they differentiate along the eosinophilic lineage. The results were compared to the eosoniphilic inducers interleukin-5 (IL-5) and butyric acid. IFN-γ (100 U/ml) and TNF-α (1000 U/ml) or IL-5 (200 pM) caused a significant increase in the expression of the eosinophil peroxidase (EPO) and the major basic protein (MBP) genes. Similar results were observed when the cells were cultured with 0.5 mM butyric acid for 5 days. IFN-γ (100 U/ml) and TNF-α (1000 U/ml) also caused a significant increase in superoxide release by HL-60 clone 15 cells after 2 days compared with control or with butyric acid-induced cells. After 5 days, these cytokines and butyric acid induced an even stronger release of superoxide. HL-60 clone 15 cells cultured with IFN-γ and TNF-α for 2 days showed a significant increase in gp91-phox gene expression. We conclude that IFN-γ and TNF-α are sufficient to induce the differentiation of HL-60 clone 15 cells to the eosinophilic lineage and to upregulate gp91-phox gene expression and activity of the NADPH oxidase system.2312737744Weller, P.F., Eosinophils: Structure and functions (1994) Curr. Opin. Immunol., 6, pp. 85-90Hua, J., Hasebe, T., Someya, A., Nakamura, S., Sugimoto, K., Nagaoka, I., Someya, A., Nagaoka, I., Evaluation of the expression of NADPH oxidase components during maturation of HL-60 cells to neutrophil lineage (2000) J. Leukocyte Biol., 68, pp. 216-224Moqbel, R., Hamid, Q., Ying, S., Barkans, J., Hartnell, A., Tsicopoulos, A., Wardlaw, A.J., Kay, A.B., Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils (1991) J. Exp. Med., 174, pp. 749-752Kita, H., Ohnishi, T., Okubo, Y., Weiler, D., Abrams, J.S., Gleich, G.J., Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils (1991) J. Exp. Med., 174, pp. 745-748Desreumaux, P., Janin, A., Colombel, J.F., Prin, L., Plumas, J., Emilie, D., Torpier, G., Capron, M., Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with celiac disease (1992) J. Exp. Med., 175, pp. 293-296Sanderson, C.J., Interleukin-5, eosinophils, and disease (1992) Blood, 79, pp. 3101-3109Collins, P.D., Marleau, S., Griffiths-Johnson, D.A., Jose, P.J., Williams, T.J., Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo (1995) J. Exp. Med., 182, pp. 1169-1174Weller, P.F., The immunobiology of eosinophils (1991) N. Engl. J. Med., 324, pp. 1110-1118Luttmann, W., Dauer, E., Schmidt, S., Marx, O., Hossfeld, M., Matthys, H., Virchow, J., Effects on interferon-7 and tumour necrosis factor-α on CD95/Fas ligand-mediated apoptosis in human blood eosinophils (2000) Scand. J. Immunol., 51, pp. 54-59Bolscher, B.G., Koenderman, L., Tool, A.T., Stokman, P.M., Roos, D., NADPH:O2 oxidoreductase of human eosinophils in the cell-free system (1990) FEBS Lett., 268, pp. 269-273Hua, J., Hasebe, T., Someya, A., Nakamura, S., Sugimoto, K., Nagaoka, I., Evaluation of the expression of NADPH oxidase components during maturation of HL-60 clone 15 cells to eosinophilic lineage (2001) Inflamm. Res., 50, pp. 156-167Newburger, P.E., Dai, Q., Whitney, C., In vitro regulation of human phagocyte cytochrome b heavy and light chain gene expression by bacterial lipopolysaccharide and recombinant human cytokines (1991) J. Biol. Chem., 266, pp. 16171-16177Condino-Neto, A., Whitney, C., Newburger, P.E., Dexamethasone but not indomethacin inhibits human phagocyte nicotinamide adenine dinucleotide phosphate oxidase activity by down-regulating expression of genes encoding oxidase components (1998) J. Immunol., 161, pp. 4960-4967Ezekowitz, R.A., Orkin, S.H., Newburger, P.E., Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease (1987) J. Clin. Invest., 80, pp. 1009-1016Condino-Neto, A., Newburger, P.E., Interferon-gamma improves splicing efficiency of CYBB gene transcripts in an interferon-responsive variant of chronic granulomatous disease due to a splice site consensus region mutation (2000) Blood, 95, pp. 3548-3554Ishibashi, F., Mizukami, T., Kanegasaki, S., Motoda, L., Kakinuma, R., Endo, F., Nunoi, H., Improved superoxide-generating ability by interferon gamma due to splicing pattern change of transcripts in neutrophils from patients with a splice site mutation in CYBB gene (2001) Blood, 98, pp. 436-441Fischkoff, S.A., Graded increase in probability of eosinophilic differentiation of HL-60 promyelocytic leukemia cells induced by culture under alkaline conditions (1988) Leuk. Res., 12, pp. 679-686Plaetinck, G., Van Der Heyden, J., Tavernter, J., Fache, I., Tuypens, T., Fischkoff, S., Fiers, W., Devos, R., Characterization of interleukin 5 receptors on eosinophilic sublines from human promyelocytic leukemia (HL-60) cells (1990) J. Exp. Med., 172, pp. 683-691Maniatis, T., Fritsch, E.F., Sambrook, J., (1990) Molecular Cloning: A Laboratory Manual, 2nd Ed., , Cold Spring Harbor, NY: Cold Spring Harbor Laboratory PressMcCord, J.M., Fridovich, I., Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein) (1969) J. Biol. Chem., 244, pp. 6049-6055Bhattacharyya, G.K., Johnson, R.A., Non-parametric inference (1977) Statistical Concepts and Methods, pp. 505-547. , G.K. Bhattacharyya and R.A. Johnson (eds.) Singapore: John WileyCollins, S.J., The HL-60 promyelocytic leukemia cell line: Proliferation, differentiation, and cellular oncogene expression (1987) Blood, 70, pp. 1233-1244Rosenberg, H.F., Dyer, K.D., Li, F., Characterization of eosinophils generated in vitro from CD34+ peripheral blood progenitor cells (1996) Exp. Hematol., 24, pp. 888-893Fischkoff, S.A., Pollak, A., Gleich, G.J., Testa, J.R., Misawa, S., Reber, T.J., Eosinophilic differentiation of the human promyelocytic leukemia cell line HL-60 (1984) J. Exp. Med., 160, pp. 179-196Hashida, R., Ogawa, K., Miyagawa, M., Sugita, Y., Matsumoto, K., Akasawa, A., Saito, H., Gene expression accompanied by differentiation of cord blood-derived CD34+ cells to eosinophils (2001) Int. Arch. Allergy Immunol., 125 (1 SUPPL.), pp. 2-6Ishizuka, T., Morita, K., Hisada, T., Ando, S., Adachi, M., Dobashi, K., Mori, M., The direct effect of interferon-gamma on human eosinophilic leukemia cell lines: The induction of interleukin-5 mRNA and the presence of an interferon-gamma receptor (1996) Inflammation, 20, pp. 151-163Horie, S., Gleich, G.J., Kita, H., Cytokines directly induce degranulation and superoxide production from human eosinophils (1996) J. Allergy Clin. Immunol., 98, pp. 371-381Nancey, S., Bienvenu, J., Coffin, B., Andre, F., Descos, L., Flourie, B., Butyrate strongly inhibits in vitro stimulated release of cytokines in blood (2002) Dig. Dis. Sci., 47, pp. 921-928Shalit, M., Sekhsaria, S., Malech, H.L., Modulation of growth and differentiation of eosinophils from human peripheral blood CD34+ cells by IL-5 and other growth factors (1995) Cell. Immunol., 160, pp. 50-57Takamoto, M., Sugane, K., Synergism of IL-3, IL-5, and GM-CSF on eosinophil differentiation and its application for an assay of murine IL-5 as an eosinophil differentiation factor (1995) Immunol. Lett., 45, pp. 43-46Ochiai, K., Omura, M., Mochizuki, A., Ito, M., Tomioka, H., Human umbilical vein endothelial cells support interleukin-3- and interleukin-5-induced eosinophil differentiation from cord blood CD34 + cells (1999) Int. Arch. Allergy Immunol., 120 (1 SUPPL.), pp. 2-6Newburger, P.E., Ezekowitz, R.A., Whitney, C., Wright, J., Orkin, S.H., Induction of phagocyte cytochrome b heavy chain gene expression by interferon gamma (1988) Proc. Natl. Acad. Sci. USA, 85, pp. 5215-5219Yoshie, O., Majima, T., Saito, H., Membrane oxidative metabolism of human eosinophilic cell line EoL-1 in response to phorbol diester and formyl peptide: Synergistic augmentation by interferon-gamma and tumor necrosis factor (1989) J. Leukocyte Biol., 45, pp. 10-20Ohtsu, H., Yamauchi, K., Yoshie, O., Tanno, Y., Saito, H., Hayashi, N., Takishima, T., The effect of cytokines on the differentiation of an eosinophilic leukemia cell line (EoL-1) is associated with down regulation of c-myc gene expression (1993) Cell Struct. Funct., 18, pp. 125-133Newburger, P.E., Ezekowitz, R.A., Cellular and molecular effects of recombinant interferon gamma in chronic granulomatous disease (1988) Hematol. Oncol. Clin. North Am., 2, pp. 267-276Leckie, M.J., Brinke, A., Khan, J., Diamant, Z., O'Connor, B.J., Walls, C.M., Mathur, A.K., Djukanovic, R., Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, air-way hyper-responsiveness, and the late asthmatic response (2000) Lancet, 356, pp. 2114-2126Kips, J.C., O'Connor, B.J., Langley, S.J., Woodcock, A., Kerstjens, H., Postman, D.S., Danzig, M., Pauwels, R.A., Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: A pilot study (2003) Am. J. Respir. Crit. Care Med., 167, pp. 1655-1659Key, A.B., Eosinophils and interleukin-5: The debate continues (2003) Am. J. Respir. Crit. Care Med., 167, pp. 1586-1587